Medical Information Market Size, Share, and Trends 2025 to 2034

Medical Information Market Size and Trends

The medical information market size was exhibited at USD 3.45 billion in 2024 and is projected to hit around USD 7.0 billion by 2034, growing at a CAGR of 7.33% during the forecast period 2025 to 2034.

Medical Information Market Key Takeaways:

• North America dominated the market with the largest revenue share of 39% in 2024.
• Asia Pacific is expected to host the fastest-growing market during the forecast period.
• By service provider, the outsourcing segment holds the largest revenue share of 58% in 2024.
• By service provider, the in-house segment is expected to witness the fastest growth in the market during the forecast period.
• By therapeutic area, the oncology segment has held a biggest revenue share of 34% in 2024.
• By therapeutic area, the immunology segment is expected to grow rapidly in the market during the forecast period.
• By product life cycle, the clinical phase segment led the market with the major revenue share of 50% in 2024.
• By product life cycle, the post-market approval segment is expected to expand significantly in the market during the forecast period.
• By company size, the medium-sized segment has contributed more than 51%of revenue share in 2024.
• By company size, the small-sized segment is expected to grow at a considerable CAGR in the market during the forecast period.
• By end-use, the pharmaceuticals segment has held a major revenue share of 43% in 2024.
• By end-use, the innovators segment is expected to grow at the fastest rate in the market during the forecast period.

U.S. Medical Information Market Size and Growth 2025 to 2034

The U.S. medical information market size was valued at USD 810.15 million in 2024 and is expected to reach around USD 1694.76 million by 2034, growing at a CAGR of 7.66% from 2025 to 2034.

In 2024, North America dominated the global medical information market, driven by the increasing adoption of medical information systems that provide healthcare professionals with evidence-based data to support clinical decisions. These systems enable secure sharing of patient information across various healthcare organizations. With rising healthcare costs, providers are under pressure to implement more cost-efficient information systems to enhance operational efficiency and reduce expenses. However, a significant challenge remains in ensuring seamless interoperability between different platforms and systems.

Asia Pacific Market Growth

The Asia Pacific medical information market is projected to experience the fastest growth during the forecast period. Several key factors are fueling this expansion, including the widespread adoption of post-marketing pharmacovigilance, healthcare IT solutions, and medical devices. The integration of telehealth, artificial intelligence, and digital health technologies is significantly improving healthcare delivery and patient monitoring. Countries such as China and Japan are leading in the adoption of these technologies, including advanced diagnostic tools and remote healthcare services. Additionally, rising healthcare expenditures in nations like China, South Korea, and India are driving demand for medical devices and information systems. The expanding middle class, which is increasingly willing to invest in healthcare, further strengthens this growth.

Medical Information Market Overview

The medical information market is a crucial component of the broader healthcare industry, encompassing the creation, management, and exchange of health-related data. This sector includes electronic health records (EHRs), medical information systems, health information exchanges (HIEs), telemedicine, and healthcare analytics.

Health Information Exchanges (HIEs) enhance interoperability by enabling the seamless exchange of medical data across various healthcare entities, ultimately improving patient care. The COVID-19 pandemic accelerated the adoption of remote healthcare solutions, leading to a significant surge in the telemedicine sector. This market segment focuses on leveraging health data analytics to improve efficiency, reduce costs, and enhance patient outcomes.

Government policies and financial incentives play a critical role in driving the adoption of EHRs and other health IT solutions. Regulatory frameworks, such as the U.S. Health Information Technology for Economic and Clinical Health (HITECH) Act, have been instrumental in advancing the implementation of sophisticated medical information systems. The healthcare sector’s ongoing focus on cost reduction and operational efficiency continues to fuel the expansion of innovative health IT solutions worldwide.

Medical Information Market Growth Factors

• Better data management, accessibility, and interoperability are made possible by the widespread use of EHRs, which is essential for healthcare practitioners. Strong medical information systems are becoming more and more necessary due to the COVID-19 pandemic and the expansion of telehealth services.
• For compliance and reporting, organizations such as the FDA, EMA, and other national health agencies require precise and thorough medical information systems.
• Data analytics is being used more and more by healthcare payers and providers to streamline operations, cut expenses, and raise patient care standards. To track patient outcomes and costs during the transition from volume-based to value-based care models, precise and comprehensive medical data are needed.
• The market growth is being fueled by technological advances, the increasing digitization of healthcare, and the growing emphasis on data-driven healthcare solutions.
• Advanced data management and analytics solutions are becoming increasingly necessary due to the explosion of medical data coming from a variety of sources, such as wearable technology, genomics, and health apps. Systems that can combine and interpret data from many sources to present a complete picture of a patient's health are becoming more and more necessary.
• Patient-centered care, in which people are more involved in their healthcare decisions and have access to their health information, is becoming more and more popular.  Patients who are more aware of and literate about health issues demand improved education and informational resources.
• Growth in the health tech industry is being driven by large investments made by private equity and venture capital firms in health tech startups and breakthroughs. The modernization of healthcare infrastructure and government investment are two further factors driving industry expansion.

Report Scope of Medical Information Market

Market Dynamics

Driver: Rising Incidence of Chronic Diseases

The increasing prevalence of chronic conditions such as diabetes, heart disease, and arthritis has heightened the need for precise and easily comprehensible medical information to aid patients in effectively managing their health. The expansion of telemedicine has further fueled demand for credible digital platforms that provide remote access to medical information. Electronic Health Records (EHRs) play a crucial role in tracking patient histories and ensuring that healthcare professionals can access relevant data seamlessly.

Additionally, pharmaceutical companies are heavily investing in research and development for chronic disease treatments, driving the demand for comprehensive medical data. Leveraging big data and health analytics is essential for forecasting chronic disease trends and patient outcomes, making detailed and accurate medical records indispensable.

Restraint: Challenges in Data Privacy and Security

Due to the sensitive nature of healthcare information, data privacy and security remain major concerns in the medical information market. Vast amounts of electronic health records (EHRs) and personal health information (PHI) are continuously collected, stored, and analyzed. Ensuring data confidentiality and integrity is crucial for maintaining regulatory compliance, protecting patient rights, and fostering public trust in healthcare organizations.

With the rising threat of cyberattacks, healthcare data has become a key target for ransomware attacks and data breaches. Striking a balance between data privacy and the need for data sharing to support medical research and improved healthcare outcomes remains a significant challenge.

Opportunity: Expansion of Telemedicine and Telehealth

The growing adoption of telemedicine and telehealth has revolutionized the medical information market, enhancing both healthcare accessibility and service delivery. These advancements rely on electronic communication and software to provide remote medical care without requiring physical consultations. Services include video consultations, real-time health monitoring, and digital medical data transmission.

Devices and applications that track vital health parameters such as blood pressure and glucose levels allow healthcare professionals to monitor patients remotely, reducing the need for physical medical infrastructure. These innovations help decrease hospital admissions and travel expenses, creating significant growth opportunities for companies operating in the medical information sector.

Medical Information Market By Service Provider Insights

Outsourcing Segment Leads the Market

The outsourcing sector accounted for the largest share of the medical information market in 2024. Companies leverage outsourcing to reduce operating costs, saving on salaries, training, and infrastructure associated with maintaining in-house teams. By utilizing third-party expertise, businesses can scale operations in response to demand fluctuations without the burden of hiring or layoffs. This flexibility is especially valuable in the dynamic healthcare industry. By delegating non-core functions, healthcare organizations can focus on primary objectives such as patient care and clinical research, leading to enhanced efficiency and productivity. Outsourcing also aids in regulatory compliance, facilitating interactions with governing bodies and ensuring adherence to industry regulations.

In-House Segment Witnessing Rapid Growth

The in-house segment is projected to experience the fastest expansion in the medical information market over the forecast period. In this model, pharmaceutical and healthcare firms manage their medical information operations internally, rather than outsourcing. This approach grants organizations greater control over their processes, allowing them to tailor operations to specific needs while maintaining brand integrity and compliance with internal policies. Managing medical information (MI) internally enhances data security and confidentiality, ensuring that sensitive information remains within the company. Additionally, in-house teams develop deep product knowledge, improving the quality of medical information provided to patients and healthcare professionals.

Medical Information Market By Therapeutic Area Insights

Oncology Segment Dominates the Market

The oncology sector held the largest share of the medical information market in 2024. This field is rapidly expanding due to the rising prevalence of cancer, scientific advancements, and the need for personalized treatment solutions. Increased cancer screening awareness, the introduction of novel therapies, and technological innovations have significantly contributed to market growth. The growing use of telemedicine services has further improved access to specialized cancer care, allowing patients to receive follow-up consultations and treatment guidance remotely.

Immunology Segment Expected to Grow Rapidly

The immunology sector is poised for significant expansion in the medical information market. Immunology encompasses research on the immune system, immune-related disorders, and the development of treatments to regulate immune responses. This field plays a critical role in managing autoimmune diseases, allergies, infectious diseases, and cancer. The rising incidence of autoimmune conditions and growing awareness of their complexity are driving demand for specialized diagnostics and treatments. Additionally, advancements in diagnostic technologies and the increasing prevalence of allergies are fueling growth in the allergy diagnostics and treatment sector.

Medical Information Market By Product Life Cycle Insights

Clinical Phase Holds the Largest Market Share

The clinical phase segment dominated the medical information market in 2024. This stage, commonly referred to as the clinical trial phase, is integral to the development and regulatory approval of new drugs and medical treatments. Prior to human trials, new medications undergo rigorous testing in laboratories and on animal models. If clinical trials demonstrate safety and efficacy, data is submitted to regulatory bodies such as the FDA (U.S.) or EMA (Europe) for approval. Even after approval, drugs undergo continuous monitoring to identify long-term effects or rare side effects in the general population.

Post-Market Approval Segment Growing Significantly

The post-market approval (PMA) segment is expected to expand considerably in the medical information market. PMA involves the monitoring and evaluation of pharmaceutical products and medical devices after regulatory approval and commercial launch. This phase ensures that products maintain quality, safety, and efficacy even after becoming widely available. In many regions, manufacturers must submit Periodic Safety Update Reports (PSURs) to regulatory authorities to report any adverse events. Other post-market measures include modifying labels, implementing additional user training, or issuing product recalls when necessary. Regulatory agencies conduct regular inspections to ensure compliance with Good Manufacturing Practices (GMP) and industry standards.

Medical Information Market By Company Size Insights

Medium-Sized Companies Leading the Market

In 2024, medium-sized enterprises held the largest market share in the medical information industry. These companies often focus on specific medical niches, fostering innovation in specialized medical information services and products. They conduct clinical trials and epidemiological research, contributing valuable insights to the broader healthcare ecosystem. Unlike large corporations, which may be less flexible, mid-sized firms offer customized medical information solutions tailored to the needs of patients, pharmaceutical companies, and healthcare providers. Additionally, these companies play a crucial role in developing and implementing health informatics solutions, including Electronic Health Records (EHRs), Health Information Exchanges (HIEs), and telemedicine platforms.

Small-Sized Companies Expected to Expand Rapidly

The small business segment is projected to grow at a notable CAGR in the medical information market. Smaller firms often drive innovation due to their ability to quickly adapt to new technologies and emerging healthcare needs. Many specialize in niche markets, focusing on rare diseases, specific medical conditions, or underserved patient populations—areas that larger firms may overlook. Small companies are also key players in health IT development, creating cutting-edge solutions such as EHR systems, telemedicine applications, and mobile health apps. Additionally, they frequently collaborate with larger pharmaceutical and biotech firms, providing specialized services and expertise to complement bigger industry players.

Medical Information Market By End-Use Insights

Pharmaceutical Segment Dominates the Market

The pharmaceutical sector accounted for the largest share of the medical information market in 2024. Pharmaceutical companies are a primary source of drug-related information, producing detailed medication records that include dosage guidelines, safety data, and prescribing information. Healthcare providers rely on these resources to make informed treatment decisions. Additionally, pharmaceutical firms develop educational materials—such as brochures, online resources, and instructional programs—to inform patients and medical professionals about diseases, treatments, and best healthcare practices. The industry is also seeing growing investments in digital health solutions, including mobile apps and online platforms that provide real-time medical information and support.

Innovators Segment Growing at the Fastest Pace

The innovators segment is anticipated to register the highest growth rate in the medical information market. Several pioneering platforms are shaping the industry:

• Epocrates – A mobile medical reference app that offers healthcare providers clinical information, including drug safety data, prescribing guidelines, and diagnostic tools.
• Doximity – A professional networking platform designed for medical practitioners, allowing secure collaboration, communication, and knowledge sharing.
• Zocdoc – A digital healthcare resource enabling patients to find and book appointments with nearby healthcare professionals. It also provides patient reviews and ratings, helping users make informed healthcare choices.

Some of The Prominent Players in The Medical Information Market Include:

• Black Rock
• UTI Mutual Fund
• Morgan Stanley
• PIMCO
• DSP Mutual Fund
• Trustee
• JPMorgan Chase & Co
• Capital Group
• Vanguard

Medical Information Market Recent Developments

• In January 2024, Swoop, a pioneer in creating accurate audiences for pharmaceutical and life sciences products through direct-to-consumer (DTC) and healthcare provider (HCP) marketing, today announced the release of its conversational agent driven by artificial intelligence. This innovative development in healthcare marketing raises the bar for lower funnel engagement by providing instantaneous brand. com-based virtual consumer encounters that comply with MLR.
  
  
• In May 2024, with immediate effect, DNA Communications, a division of The Weber Shandwick Collective, introduced the DNA Medical Education Center, a health education communications product, in the United States. Since the agency's founding in 2011, the UK version of the center has been operational, according to DNA President Mike Rosich.

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the Medical Information Market

By Service Provider

• In House
• Contract Outsourcing

By Therapeutic Area

• Oncology
• Neurology
• Cardiology
• Immunology
• Others

By Product Life Cycle

• Pre-clinical
• Clinical
• Post-market Approval

By Company Size

• Small
• Medium
• Large Scale

By End-use

• Pharmaceuticals
• Biotechnology Companies
• Medical Device Manufacturers

By Regional

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)